Current and Next Generation Therapeutics in Hepatology, An Issue of Clinics in Liver Disease
- 1st Edition, Volume 29-4 - October 24, 2025
- Latest edition
- Editor: Vinod K. Rustgi
- Language: English
In this issue of Clinics in Liver Disease, guest editor Dr. Vinod K. Rustgi brings his considerable expertise to the topic of Current and Next Generation Therapeutics in Hepatolog… Read more
Purchase options
Description
Description
In this issue of Clinics in Liver Disease, guest editor Dr. Vinod K. Rustgi brings his considerable expertise to the topic of Current and Next Generation Therapeutics in Hepatology. Top experts in hepatology provide updates on the latest pharmaceuticals available as well as those in the pipeline for a wide range of liver diseases.
Key features
Key features
- Contains 11 relevant, practice-oriented topics including primer of CRISPR: gene therapy and molecular therapies; evolving treatments of cirrhosis; what is coming in the world of liver transplantation; weight loss drugs: current and future implications for liver disease; sensors and wearables in hepatology; and more
- Provides in-depth clinical reviews on current and next generation therapeutics in hepatology, offering actionable insights for clinical practice
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
Readership
Readership
Hepatologists
Table of contents
Table of contents
Liver-Directed Molecular Therapies: Current and Upcoming Strategies
New Approaches to Alcohol-Associated Hepatitis
Therapies and Pipeline for Hepatitis B and Hepatitis D
Recent Advances in Primary Biliary Cholangitis Treatment
Current Status and Future Directions in the Pharmacologic Management of Cirrhosis
Novel Therapeutics for Hepatocellular Carcinoma
Current Focus and Innovation in Liver Transplantation
Radiomics in Hepatology: Therapeutic Applications in Hepatocellular Carcinoma
Current and Future Implications of Weight Loss Drugs on Liver Disease
Artificial Intelligence and Machine Learning Applications in Liver Disease
Pediatric Liver Diseases: Next-Generation Therapies
Future Treatment Options for Managing Primary Sclerosing Cholangitis and Cholestatic Pruritus
New Approaches to Alcohol-Associated Hepatitis
Therapies and Pipeline for Hepatitis B and Hepatitis D
Recent Advances in Primary Biliary Cholangitis Treatment
Current Status and Future Directions in the Pharmacologic Management of Cirrhosis
Novel Therapeutics for Hepatocellular Carcinoma
Current Focus and Innovation in Liver Transplantation
Radiomics in Hepatology: Therapeutic Applications in Hepatocellular Carcinoma
Current and Future Implications of Weight Loss Drugs on Liver Disease
Artificial Intelligence and Machine Learning Applications in Liver Disease
Pediatric Liver Diseases: Next-Generation Therapies
Future Treatment Options for Managing Primary Sclerosing Cholangitis and Cholestatic Pruritus
Product details
Product details
- Edition: 1
- Latest edition
- Volume: 29-4
- Published: October 24, 2025
- Language: English
About the editor
About the editor
VR
Vinod K. Rustgi
Dr. Vinod Rustgi is a Professor in Epidemiology in the School of Public Health and a Professor in Pathology and Lab Medicine. He previously served as Program Director for the Gastroenterology Fellowship until the 2022/2023 academic year and currently serves as Associate Program Director. He has extensive experience in hepatology spanning over 30 years and previously held the position of Medical Director of Liver Transplantation at the University of Pittsburgh’s Starzl Transplant Institute. His research and clinical interests include outcomes research in nonalcoholic steatohepatitis (NASH), other liver diseases, and cost-effectiveness modeling. He has contributed to antiviral research associated with hepatitis C cure efforts and has served on the Governing Board of the American Association for the Study of Liver Diseases (AASLD).
Affiliations and expertise
Distinguished Professor, Associate Program Director, Clinical Director of Hepatology, and Director, Center for Liver Diseases, Robert Wood Johnson Medical School (RWJMS), Rutgers Health, New Brunswick, NJ, USA